{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:46:32Z","timestamp":1791751592024,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","award":["ALF 2022 YF 0017"],"award-info":[{"award-number":["ALF 2022 YF 0017"]}],"id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1185180"],"award-info":[{"award-number":["1185180"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019774","name":"CRC for Mental Health Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003186","name":"Fredrik and Ingrid Thurings Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005701","name":"Maja & JP \u00c5hl\u00e9n Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006075","name":"Greta and Johan Kock Foundations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.schres.2026.09.045","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:04:44Z","timestamp":1791356684000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Astrocytic activity in treatment-resistant and ultra-treatment-resistant schizophrenia"],"prefix":"10.1016","volume":"298","author":[{"given":"Claudia","family":"Cicognola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhamidhu","family":"Eratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.Y.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorena","family":"Janelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Malpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsuan","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra M.J.","family":"Wannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Bousman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Everall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Velakoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Pantelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander F.","family":"Santillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0005","doi-asserted-by":"crossref","first-page":"14798","DOI":"10.1038\/s41598-018-33158-8","article-title":"Serum GFAP as a biomarker for disease severity in multiple sclerosis","volume":"8","author":"Abdelhak","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.schres.2026.09.045_bb0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/JAD-200755","article-title":"Plasma glial fibrillary acidic protein levels differ along the spectra of amyloid burden and clinical disease stage","volume":"78","author":"Asken","year":"2020","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.schres.2026.09.045_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2024.100111","article-title":"Impaired cognitive flexibility in schizophrenia: a systematic review of behavioral and neurobiological findings","volume":"11","author":"Aumer","year":"2024","journal-title":"Biomark. Neuropsych."},{"issue":"9","key":"10.1016\/j.schres.2026.09.045_bb0025","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","article-title":"Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study","volume":"17","author":"Bazarian","year":"2018","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.schres.2026.09.045_bb0030","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.schres.2026.09.045_bb0035","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3233\/JAD-200608","article-title":"Serum glial fibrillary acidic protein (GFAP) is a marker of disease severity in frontotemporal lobar degeneration","volume":"77","author":"Benussi","year":"2020","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0040","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/s41598-019-38490-1","article-title":"Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia","volume":"9","author":"Bousman","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12026-025-09674-x","article-title":"GFAP as a marker of astrocytic damage correlated with medication overuse in migraine","volume":"73","author":"Carta","year":"2025","journal-title":"Immunol. Res."},{"issue":"12","key":"10.1016\/j.schres.2026.09.045_bb0050","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1474-4422(25)00249-2","article-title":"Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications","volume":"24","author":"Chitnis","year":"2025","journal-title":"Lancet Neurol."},{"issue":"16","key":"10.1016\/j.schres.2026.09.045_bb0055","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1093\/hmg\/ddq227","article-title":"Drug screening to identify suppressors of GFAP expression","volume":"19","author":"Cho","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.schres.2026.09.045_bb0060","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020370","article-title":"Astrocytes control synapse formation, function, and elimination","volume":"7","author":"Chung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"3","key":"10.1016\/j.schres.2026.09.045_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/00048674241307906","article-title":"Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia","volume":"59","author":"Cilia","year":"2025","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.schres.2026.09.045_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2023.110680","article-title":"Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population","volume":"121-122","author":"Cooper","year":"2023","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.schres.2026.09.045_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.euroneuro.2025.07.004","article-title":"Blood-based biomarkers of neuroaxonal and astroglial injury identify ultra-treatment-resistant schizophrenia","volume":"99","author":"de Oliveira","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.09.045_bb0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2017.01.021","article-title":"Drugs targeting intermediate filaments can improve neurosupportive properties of astrocytes","volume":"136","author":"de Pablo","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.schres.2026.09.045_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2026.113155","article-title":"Serum and plasma glial fibrillary acidic protein in patients with schizophrenia: a systematic review and meta-analysis","volume":"220","author":"Ebrahimi","year":"2026","journal-title":"Exp. Gerontol."},{"issue":"10","key":"10.1016\/j.schres.2026.09.045_bb0095","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/00048674211058684","article-title":"Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives","volume":"56","author":"Eratne","year":"2022","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.045_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123291","article-title":"Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders","volume":"467","author":"Eratne","year":"2024","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s13064-018-0104-y","article-title":"Astrocytes, neurons, synapses: a tripartite view on cortical circuit development","volume":"13","author":"Farhy-Tselnicker","year":"2018","journal-title":"Neural Dev."},{"issue":"1\u20133","key":"10.1016\/j.schres.2026.09.045_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.05.016","article-title":"Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats","volume":"104","author":"Fatemi","year":"2008","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.schres.2013.07.024","article-title":"Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness","volume":"150","author":"Feresten","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.045_bb0120","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV)","author":"First","year":"1996"},{"issue":"20","key":"10.1016\/j.schres.2026.09.045_bb0125","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1073\/pnas.200033797","article-title":"Measuring the thickness of the human cerebral cortex from magnetic resonance images","volume":"97","author":"Fischl","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12888-016-1177-y","article-title":"Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review","volume":"17","author":"Gillespie","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0135","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41467-019-09131-y","article-title":"Ventral tegmental area astrocytes orchestrate avoidance and approach behavior","volume":"10","author":"Gomez","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.schres.2026.09.045_bb0140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.biopsych.2024.03.011","article-title":"Accelerated cortical thinning in schizophrenia is associated with rare and common predisposing variation to schizophrenia and neurodevelopmental Disorders","volume":"96","author":"Gonz\u00e1lez-Pe\u00f1as","year":"2024","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0145","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1038\/s41598-025-89555-3","article-title":"An experimental and computational investigation of executive functions and inner speech in schizophrenia spectrum disorders","volume":"15","author":"Granato","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.schres.2026.09.045_bb0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.045_bb0155","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbi.2024.11.001","article-title":"Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: a systematic review and meta-analysis","volume":"123","author":"Jy Kang","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.schres.2026.09.045_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2026.09.045_bb0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1176\/appi.ajp.2014.14040516","article-title":"IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk","volume":"172","author":"Kendler","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.09.045_bb0170","doi-asserted-by":"crossref","first-page":"e2410684","DOI":"10.1001\/jamanetworkopen.2024.10684","article-title":"In vivo reactive astrocyte imaging in patients with schizophrenia using fluorine 18\u2013labeled THK5351","volume":"7","author":"Kim","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.schres.2026.09.045_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1358450","article-title":"The role of glial cells in mental illness: a systematic review on astroglia and microglia as potential players in schizophrenia and its cognitive and emotional aspects","volume":"18","author":"Laricchiuta","year":"2024","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2026.09.045_bb0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.eurpsy.2006.11.004","article-title":"Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB","volume":"22","author":"Levaux","year":"2007","journal-title":"Eur. Psychiatry"},{"issue":"8004","key":"10.1016\/j.schres.2026.09.045_bb0185","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41586-024-07109-5","article-title":"A concerted neuron\u2013astrocyte program declines in ageing and schizophrenia","volume":"627","author":"Ling","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.schres.2026.09.045_bb0190","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/mp.2015.148","article-title":"Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?","volume":"21","author":"McCullumsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.09.045_bb0195","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","article-title":"Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment","volume":"28","author":"McCutcheon","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.045_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104547","article-title":"Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with down syndrome: a longitudinal cohort study","volume":"90","author":"Montoliu-Gaya","year":"2023","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.schres.2026.09.045_bb0205","first-page":"323","article-title":"Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"issue":"12","key":"10.1016\/j.schres.2026.09.045_bb0210","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41398-017-0041-2","article-title":"Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients","volume":"7","author":"Mostaid","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.045_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2025.107065","article-title":"Schizophrenia-associated complement component C4 induces maturation and reactivity in human astrocytes","volume":"276","author":"N\u00f3brega","year":"2025","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.schres.2026.09.045_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2018.08.016","article-title":"Treatment resistant schizophrenia: clinical, biological, and therapeutic perspectives","volume":"131","author":"Nucifora","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.schres.2026.09.045_bb0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fpsyt.2017.00293","article-title":"A brief assessment of intelligence decline in schizophrenia as represented by the difference between current and premorbid intellectual quotient","volume":"8","author":"Ohi","year":"2017","journal-title":"Front. Psych."},{"issue":"2","key":"10.1016\/j.schres.2026.09.045_bb0230","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3233\/JAD-230384","article-title":"Pre-analytical variables influencing stability of blood-based biomarkers of neuropathology","volume":"95","author":"Panikkar","year":"2023","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0235","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.schres.2009.03.039","article-title":"Attentional set-shifting ability in first-episode and established schizophrenia: relationship to working memory","volume":"112","author":"Pantelis","year":"2009","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2026.09.045_bb0240","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/alz.12787","article-title":"Confounding factors of Alzheimer\u2019s disease plasma biomarkers and their impact on clinical performance","volume":"19","author":"Pichet Binette","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.schres.2026.09.045_bb0245","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamapsychiatry.2021.4377","article-title":"Longitudinal associations of mental disorders with dementia: 30-year analysis of 1.7 million New Zealand citizens","volume":"79","author":"Richmond-Rakerd","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0250","doi-asserted-by":"crossref","first-page":"14271","DOI":"10.1038\/s41598-020-71060-4","article-title":"Plasma \u03b2-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia","volume":"10","author":"Rodrigues-Amorim","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.schres.2026.09.045_bb0255","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","article-title":"Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning","volume":"22","author":"Sellgren","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2026.09.045_bb0260","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020420","article-title":"Astrogliosis","volume":"7","author":"Sofroniew","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.schres.2026.09.045_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010061","article-title":"Neurofilament light protein as a biomarker in severe mental disorders: a systematic review","volume":"26","author":"Squitti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.schres.2026.09.045_bb0270","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1515\/cclm-2022-0646","article-title":"Serum GFAP \u2013 reference interval and preanalytical properties in Danish adults","volume":"60","author":"Tybirk","year":"2022","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"9","key":"10.1016\/j.schres.2026.09.045_bb0275","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.biopsych.2018.04.023","article-title":"Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through Meta analysis (ENIGMA) consortium","volume":"84","author":"van Erp","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2026.09.045_bb0280","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archgenpsychiatry.2011.88","article-title":"Changes in cortical thickness during the course of illness in schizophrenia","volume":"68","author":"van Haren","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.09.045_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/biom15050615","article-title":"The role of astrocytes in the molecular pathophysiology of schizophrenia: between neurodevelopment and neurodegeneration","volume":"15","author":"Vellucci","year":"2025","journal-title":"Biomolecules"},{"issue":"1\u20133","key":"10.1016\/j.schres.2026.09.045_bb0290","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2012.01.031","article-title":"Searching for a consensus five-factor model of the positive and negative syndrome scale for schizophrenia","volume":"137","author":"Wallwork","year":"2012","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2026.09.045_bb0295","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/appi.ajp.2019.18040380","article-title":"Evidence for network-based cortical thickness reductions in schizophrenia","volume":"176","author":"Wannan","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.045_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116073","article-title":"Plasma neurofilament light protein is differentially associated with age in individuals with treatment-resistant schizophrenia and bipolar affective disorder compared to controls","volume":"339","author":"Wannan","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.09.045_bb0305","series-title":"Wechsler Abbreviated Scale of Intelligence","author":"Wechsler","year":"1999"},{"issue":"5","key":"10.1016\/j.schres.2026.09.045_bb0310","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/npp.2015.277","article-title":"Dysfunctional striatal Systems in Treatment-Resistant Schizophrenia","volume":"41","author":"White","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2026.09.045_bb0315","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/NDT.S195134","article-title":"Cortical thinning and flattening in schizophrenia and their unaffected parents","volume":"15","author":"Yan","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:04:05Z","timestamp":1791749045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426003397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"alternative-id":["S0920996426003397"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.09.045","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astrocytic activity in treatment-resistant and ultra-treatment-resistant schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.09.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}